Scarica l'app Stockscreener
4.05
0.75%
0.03
Precedente Chiudi:
$4.02
Aprire:
$4.08
Volume 24 ore:
1.15M
Relative Volume:
2.25
Capitalizzazione di mercato:
$536.93M
Reddito:
$433.14M
Utile/perdita netta:
$4.95M
Rapporto P/E:
49.63
EPS:
0.0816
Flusso di cassa netto:
$6.55M
1 W Prestazione:
+4.92%
1M Prestazione:
+30.65%
6M Prestazione:
+43.62%
1 anno Prestazione:
+56.37%
Intervallo 1D:
$4.01
$4.21
Intervallo di 1 settimana:
$3.76
$4.21
Portata 52W:
$2.165
$4.705
Organogenesis Holdings Inc Stock (ORGO) Company Profile
Nome
Organogenesis Holdings Inc
Settore
Telefono
781-575-0775
Indirizzo
85 DAN ROAD, CANTON, MA
Confronta ORGO con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
| ORGO | 4.05 | 536.93M | 433.14M | 4.95M | 6.55M | 0.0816 |
| ZTS | 176.96 | 79.84B | 9.15B | 2.43B | 2.31B | 4.92 |
| HLN | 9.65 | 43.63B | 14.26B | 1.55B | 0 | 0.3327 |
| TAK | 13.38 | 42.42B | 30.27B | 1.93B | 3.45B | 0.444 |
| TEVA | 17.12 | 19.40B | 16.77B | -959.00M | 1.37B | -2.00 |
| VTRS | 13.37 | 15.96B | 15.05B | -883.30M | 1.89B | 1.53 |
Organogenesis Holdings Inc Stock (ORGO) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2024-06-28 | Iniziato | Lake Street | Buy |
| 2024-02-07 | Iniziato | Cantor Fitzgerald | Overweight |
| 2023-06-15 | Iniziato | Morgan Stanley | Equal-Weight |
| 2023-05-24 | Aggiornamento | BTIG Research | Neutral → Buy |
| 2022-11-10 | Downgrade | BTIG Research | Buy → Neutral |
| 2022-08-10 | Downgrade | Oppenheimer | Outperform → Perform |
| 2020-01-10 | Iniziato | SVB Leerink | Outperform |
| 2019-08-26 | Ripresa | Credit Suisse | Outperform |
| 2019-05-02 | Iniziato | Credit Suisse | Outperform |
| 2019-04-17 | Iniziato | Oppenheimer | Outperform |
| 2019-04-11 | Iniziato | SunTrust | Buy |
Mostra tutto
Organogenesis Holdings Inc Borsa (ORGO) Ultime notizie
Organogenesis Holdings Inc. Expands Manufacturing Capacity to Support Future Growth - Marketscreener.com
Organogenesis Expands Manufacturing Capacity to Support Future Growth - The Manila Times
Organogenesis Secures 122,000 Sq Ft Biomanufacturing Facility in Major Expansion | ORGO Stock News - StockTitan
Organogenesis Holdings Inc. Appoints Garrett Lustig to the Board - Marketscreener.com
Analysts Set Expectations for Organogenesis FY2024 Earnings - Defense World
FY2024 EPS Estimates for Organogenesis Boosted by Analyst - MarketBeat
Organogenesis Holdings’ $130 Million Private Placement Offering of Series A Convertible Preferred Stock - Global Legal Chronicle
Organogenesis (NASDAQ:ORGO) Releases Quarterly Earnings Results, Beats Expectations By $0.11 EPS - MarketBeat
Organogenesis Commends Final LCDs - The Manila Times
Organogenesis Secures Medicare Coverage for Wound Care Products in Key CMS Decision | ORGO Stock News - StockTitan
Organogenesis (NASDAQ:ORGO) Shares Gap DownWhat's Next? - MarketBeat
Earnings call: Organogenesis tops Q3 revenue forecast with $115.2M - Investing.com
Organogenesis Holdings Secures $130M Investment for Growth - TipRanks
Organogenesis Holdings Inc. (NASDAQ:ORGO) Q3 2024 Earnings Call Transcript - Insider Monkey
Organogenesis secures $130 million investment By Investing.com - Investing.com Australia
Organogenesis: Q3 Earnings Snapshot - The Washington Post
Organogenesis Reports Robust Third Quarter Growth - TipRanks
Organogenesis (ORGO) Q3 2024 Earnings Call Transcript - The Motley Fool
Organogenesis (ORGO) Tops Q3 Earnings and Revenue Estimates - Yahoo Canada Finance
Organogenesis Holdings Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com
Organogenesis Holdings Inc. Announces $130 Million Private Placement Offering of Series A Convertible Preferred Stock - The Manila Times
Organogenesis Holdings Inc. Reports Third Quarter 2024 Financial Results - The Manila Times
Organogenesis Secures $130M Investment from Avista, Strengthens Growth Strategy | ORGO Stock News - StockTitan
ORGOOrganogenesis Holdings Inc. Latest Stock News & Market Updates - StockTitan
Organogenesis Holdings Inc. announced that it expects to receive $130 million in funding from Avista Healthcare Partners - Marketscreener.com
Organogenesis Phase 3 Trial Success: ReNu Knee Treatment Shows Promising Results | ORGO Stock News - StockTitan
Advanced Wound Care Market growing at a CAGR of 5.6% from 2023 - openPR
Organogenesis (ORGO) Set to Announce Earnings on Tuesday - Defense World
$5M grant key to R.I. biotech deal in Smithfield - Providence Business News
Organogenesis Holdings And 2 Other US Penny Stocks To Watch - Simply Wall St
Mass. company offered millions to manufacture artificial skin in the Ocean State - The Business Journals
Business | McKee Administration Poised to Give Major Incentives to Boston Biotech Firm - GoLocalProv
Organogenesis eyes former Rubius site in SmithfieldProvidence Business First - The Business Journals
Mass.-based biotech firm looks to expand to former Rubius facility in Smithfield - Providence Business News
Shareholders in Organogenesis Holdings (NASDAQ:ORGO) are in the red if they invested three years ago - Yahoo Finance
Assenagon Asset Management S.A. Has $5.48 Million Holdings in Organogenesis Holdings Inc. (NASDAQ:ORGO) - MarketBeat
Organogenesis Holdings Inc. to Report Third Quarter of Fiscal Year 2024 Financial Results on November 12, 2024 - The Manila Times
Market Highlights: Organogenesis Holdings Inc (ORGO) Ends on a High Note at 3.09 - The Dwinnex
Cubist Systematic Strategies LLC Acquires 88,175 Shares of Organogenesis Holdings Inc. (NASDAQ:ORGO) - Defense World
Organogenesis: Lurking Disruption With Recovery To Follow (NASDAQ:ORGO) - Seeking Alpha
Cantor Fitzgerald Comments on Organogenesis Holdings Inc.'s FY2024 Earnings (NASDAQ:ORGO) - MarketBeat
Amniotic Membrane Market to See Booming Growth 2024-2031 | Smith - openPR
Dimensional Fund Advisors LP Raises Position in Organogenesis Holdings Inc. (NASDAQ:ORGO) - MarketBeat
Organogenesis Holdings Inc. (NASDAQ:ORGO) Shares Purchased by AQR Capital Management LLC - Defense World
AQR Capital Management LLC Grows Stock Holdings in Organogenesis Holdings Inc. (NASDAQ:ORGO) - MarketBeat
Organogenesis Announces Publication of Randomized Clinical Trial Results Demonstrating the Safety and Efficacy of NuShield for Diabetic Foot Ulcers - ForexTV.com
Healthy Upside Potential: Organogenesis Holdings Inc (ORGO) - SETE News
Organogenesis Holdings Inc. (NASDAQ:ORGO) Short Interest Update - MarketBeat
Organogenesis Holdings Inc. (NASDAQ:ORGO) Shares Acquired by Massachusetts Financial Services Co. MA - Defense World
Bank of New York Mellon Corp Increases Position in Organogenesis Holdings Inc. (NASDAQ:ORGO) - Defense World
WINTON GROUP Ltd Sells 4,139 Shares of Organogenesis Holdings Inc. (NASDAQ:ORGO) - Defense World
Organogenesis Holdings Inc Azioni (ORGO) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
3.66%
0.30%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):